Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations

SF3B1, SRSF2 and U2AF1 are the most frequently mutated splicing factor genes in the myelodysplastic syndromes (MDS). We have performed a comprehensive and systematic analysis to determine the impact of these commonly mutated splicing factors on pre-mRNA splicing in the bone marrow stem/progenitor ce...

Detaylı Bibliyografya
Asıl Yazarlar:	Pellagatti, A, Armstrong, R, Steeples, V, Sharma, E, Repapi, E, Singh, S, Sanchi, A, Radujkovic, A, Horn, P, Dolatshad, H, Roy, S, Broxholme, J, Lockstone, H, Taylor, S, Giagounidis, A, Vyas, P, Schuh, A, Hamblin, A, Papaemmanuil, E, Killick, S, Malcovati, L, Hennrich, M, Gavin, A, Ho, A, Luft, T, Hellström-Lindberg, E, Cazzola, M, Smith, C, Smith, S, Boultwood, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	American Society of Hematology 2018

Benzer Materyaller

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
Yazar:: Esoof, N, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Gene expression and risk of leukemic transformation in myelodysplasia
Yazar:: Shiozawa, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
Yazar:: Yusuke Shiozawa, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridisation (CGH)
Yazar:: Esoof, N, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
Yazar:: Papaemmanuil, E, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Spliceosome mutations: 1 plus 1 does not always equal 2
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The impact of spliceosome mutations in MDS
Yazar:: Jacqueline Boultwood, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
Yazar:: Yip, B, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
Yazar:: Armstrong, R, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
Yazar:: Malcovati, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Chromosomal deletions in myelodysplasia.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (1995)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
Yazar:: Wang, L, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
Yazar:: Dolatshad, H, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Yazar:: Boultwood, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the a thalassaemia myelodysplasia syndrome (ATMDS)
Yazar:: Gibbons, R, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the alpha thalassemia myelodysplasia syndrome (ATMDS).
Yazar:: Gibbons, R, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Glutathione S-transferase gene deletions in myelodysplasia.
Yazar:: Atoyebi, W, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Temozolomide-Induced Myelodysplasia
Yazar:: Ethan A. Natelson, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)